What are hyoscine patches?
Hyoscine is also known as scopolamine. Scopoderm is a patch product name you may see on a prescription or pack. A transdermal patch gives medicine through the skin; it is not the same preparation as a tablet or injection.
The historical UK Scopoderm leaflet describes use for preventing travel-sickness symptoms. The emc product entry was marked discontinued when checked on 11 October 2026. That is a product-listing status, not a live stock check or a statement that all possible supply routes are available or unavailable.
Use the leaflet supplied with your own pack. An older UK leaflet should not be used to infer the instructions or status of a different product.
Motion sickness and specialist saliva-management plans.
The MHRA describes the licensed patch indication as prevention of motion or travel sickness. It also notes specialist use outside the licence, including for excess saliva or respiratory secretions. Those uses need the individual clinician’s plan; this guide does not recommend a patch for someone with new symptoms.
For travel-sickness questions, a pharmacist can discuss the range of suitable approaches. For drooling or swallowing difficulties, the underlying problem and swallowing assessment matter. Non-medicine support and other clinician-led options may be relevant.
Read the saliva and swallowing guide →Why the exact patch details matter.
When discussing an existing prescription, read the medicine name, patch strength, product name and manufacturer from the dispensing label or pack. Note the quantity and the instructions already given by your clinician.
A patch’s labelled content and the way medicine is delivered over time are different concepts. Do not convert a patch into an oral dose or assume two differently described patches are interchangeable. The pharmacist can check the exact prescription and product details.
If a different pack has been suggested during an availability enquiry, keep its details and ask the pharmacy to confirm the appropriate route. This page does not identify a substitute for your prescribed patch.
A useful record for patients and carers.
Keep the product leaflet and the current written care instructions together. If several people help with medicines, make sure they are working from the same instructions and know who to contact with a question.
Tell the pharmacist about skin problems, difficulties following the patch routine or unclear instructions. Ask the clinical team to clarify any individual schedule rather than constructing one from general internet information.
For care-home or supported-living arrangements, explain who manages the patch record and who will receive a supply. The prescription, care plan and medicine records need to refer to the same item.
Read the MHRA patch safety advice.
The MHRA identifies potentially serious anticholinergic effects, including overheating, inability to pass urine, confusion, hallucinations, seizures, reduced consciousness and breathing difficulty. Its advice is to remove the patch and seek medical help immediately if those symptoms occur. Call 999 for a life-threatening emergency.
Do not improvise by cutting patches, adding extra patches or altering the schedule. Raise any instructions that are unclear with the prescriber or pharmacist. Read the full MHRA advice ↗.
Other effects such as dry mouth, blurred vision or drowsiness are described in the product information. Ask about symptoms that trouble you; the full leaflet contains more information than this summary.
Questions about an already-prescribed patch.
Have the exact product details ready and explain when the next supply is needed. If the patch is part of specialist care, say which team manages the prescription and whether the current supply comes from a hospital or community pharmacy.
A historical product listing does not establish current availability. The pharmacist must check the item, prescription route and any practical supply requirements. If an interruption is becoming likely, contact the prescribing team promptly for an individual plan.
General prescription-support and delivery information is available separately below. Delivery eligibility is confirmed by the branch for the actual prescription and postcode.
Questions patients and carers ask
Are hyoscine patches and Buscopan the same medicine?
No. Buscopan contains hyoscine butylbromide, a different medicine used for different purposes. Do not substitute it for a prescribed patch.
Does a hyoscine patch treat every cause of drooling?
No. Saliva or swallowing problems need assessment. A clinician may use a patch as part of an individual plan; that does not make it suitable for someone else.
Can the patch be cut or replaced with tablets?
Do not change the preparation or routine yourself. Ask the prescriber or pharmacist to clarify the plan for your particular product.
Does this page confirm that Scopoderm is in stock?
No. The historical emc listing is marked discontinued. The pharmacy must check current product status and any appropriate supply route for the prescription.
UK prescription questions
Understanding supply and repeat arrangements in the UK
Scopoderm, hyoscine and scopolamine: why the pack wording matters
Search results can use the active-ingredient name, a familiar brand, or wording from an overseas pack. They can also describe the amount in a patch differently from the amount released over time. Copy the actual label and prescription wording for the pharmacist instead of treating similar search results as equivalent products. Tablets, injections and patches are different formulations; this guide concerns patches.
Checking UK availability without relying on an old shortage notice
Supply notices are dated reports about particular products. An old article, a search-result snippet or a product leaflet is not a live stock check. If your pharmacy cannot obtain the prescribed patch, ask which product it has checked and whether a further update is expected. Tell the pharmacy if a prescription is already being prepared elsewhere, and establish a clear contact route for the next update.
If the patch is part of an existing saliva-management plan
Patients and carers may be coordinating supplies alongside a specialist plan. Have the product wording and your usual clinical-team contact available when seeking help. Any change of product or treatment needs the appropriate professional discussion. The presence of a patch in an online travel-sickness catalogue does not resolve whether it matches an individual's prescribed care.
A practical enquiry about the next supply
Explain whether you are asking about a routine repeat or a supply that will run out shortly. The pharmacy confirms the supply route, product details and whether collection or delivery can be arranged. Imported product questions require a pharmacist's assessment. Do not buy from an unfamiliar overseas listing on the assumption that it is the same patch or can be used in the same way. For an urgent supply problem, telephone your usual pharmacy or clinical team.
Read the UK prescription and delivery guide →
This practical section was added on 12 October 2026. Availability is confirmed directly with the pharmacy for the exact product; no live stock is shown here.
Questions about your pharmacy arrangements?
Read how prescription enquiries, collection and delivery checks work. The branch confirms arrangements for the actual prescription and address.
About prescription support →Monday–Friday, 9am–6pm. Give a brief enquiry first; the branch arranges any further information needed.
Sources and further reading
- emc: historical Scopoderm patient leaflet and product status ↗
- MHRA: hyoscine patch safety advice ↗
- NHS: hyoscine hydrobromide information; mainly tablets ↗
Information prepared by FindMyMeds. Sources checked on 11 October 2026. Medical-page approver: Ranjit Rana. Page-specific sign-off dates have not yet been recorded for this review build. Read the leaflet supplied with your actual medicine and ask a pharmacist or prescriber about individual questions.
How we prepare this information